Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Timothy Veenestra, Philip Verghese, Phillip Herrbrich

Premium

C2N Diagnostics announced three new hires this week: Timothy Veenestra as senior vice president of diagnostic services and innovation; Philip Verghese as principal scientist; and Phillip Herrbrich as laboratory manager.

Veenestra was previously director of the laboratory of proteomics and analytical technologies at the National Cancer Institute.

Verghese was a post-doctoral researcher in the laboratory of C2N scientific founder, Washington University researcher David Holtzman.

Herrbrich brings experience from working within GLP and CLIA-regulated laboratory environments, including at Mid-America Transplant Services, Barnes-Jewish Hospital, and the Washington University School of Medicine.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.